Advanced search
Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 36, 2017 - Issue 2
Submit an article Journal homepage
149
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Endoscopic dacryocystorhinostomy following radioactive iodine thyroid ablation

Sarah H. Van TasselDepartment of Ophthalmology, New York Presbyterian Hospital – Weill Cornell Medical College, New York, New York, USACorrespondence[email protected]
View further author information
,
Kira L. SegalDepartment of Ophthalmology, New York Presbyterian Hospital – Weill Cornell Medical College, New York, New York, USAView further author information
,
Nicole M. HsuDepartment of Otolaryngology - Head and Neck Surgery Group, United States Air Force Academy, Colorado Springs, Colorado, USA;Department of Otolaryngology, Head and Neck Surgery, New York Presbyterian Hospital – Weill Cornell Medical College, New York, New York, USAView further author information
,
Ashutosh KackerDepartment of Otolaryngology, Head and Neck Surgery, New York Presbyterian Hospital – Weill Cornell Medical College, New York, New York, USAView further author information
&
Gary J. Lelli Jr.Department of Ophthalmology, New York Presbyterian Hospital – Weill Cornell Medical College, New York, New York, USAView further author information
Pages 59-63 | Received 17 Mar 2016, Accepted 03 Jan 2017, Published online: 28 Feb 2017

References

  • Surveillance, Epidemiology, and End Results (SEER). Cancer of the Thyroid - SEER Stat Fact Sheets [Internet]. [cited 2016 Jan 2]. Available from: http://seer.cancer.gov/statfacts/html/thyro.html
  • Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer. BMJ 2014; 348:g3045.
  • Fard-Esfahani A, Emami-Ardekani A, Fallahi B, Fard-Esfahani P, Beiki D, Hassanzadeh-Rad A, et al. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Nucl Med Commun 2014 Aug; 35(8):808–817.
  • Alexander C, Bader JB, Schaefer A, Finke C, Kirsch CM. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med Off Publ Soc Nucl Med 1998 Sep; 39(9):1551–1554.
  • Jung S-K, Kim Y-C, Cho W-K, Paik J-S, Yang S-W. Surgical outcomes of endoscopic dacryocystorhinostomy: analysis of 1083 consecutive cases. Can J Ophthalmol 2015 Dec; 50(6):466–470.
  • Kim C, Kacker A, Pearlman AN, Lelli GJ. Results of combined multispecialty endoscopic dacryocystorhinostomy. Orbit Amst Neth 2013 Aug; 32(4):235–238.
  • Kloos RT, Duvuuri V, Jhiang SM, Cahill KV, Foster JA, Burns JA. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 2002 Dec; 87(12):5817–5820.
  • Al-Qahtani KH, Al Asiri M, Tunio MA, Aljohani NJ, Bayoumi Y, Munir I, et al. Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases. Clin Ophthalmol Auckl NZ 2014; 8:2479–2484.
  • Burns JA, Morgenstern KE, Cahill KV, Foster JA, Jhiang SM, Kloos RT. Nasolacrimal obstruction secondary to I(131) therapy. Ophthal Plast Reconstr Surg 2004 Mar; 20(2):126–129.
  • Fard-Esfahani A, Farzanefar S, Fallahi B, Beiki D, Saghari M, Emami-Ardekani A, et al. Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer. Nucl Med Commun 2012 Oct;33(10):1077–1080.
  • Sun GEC, Hatipoglu B. Epiphora after radioactive iodine ablation for thyroid cancer. Thyroid Off J Am Thyroid Assoc 2013 Feb; 23(2):243–245.
  • Ramakrishnan VR, Durairaj VD, Kingdom TT. Endoscopic management of acquired nasolacrimal duct obstruction secondary to radioactive iodine treatment for thyroid maligancy. J Aller Ther 2011 Jun 4; 2(2):1–4.
  • Morgenstern KE, Vadysirisack DD, Zhang Z, Cahill KV, Foster JA, Burns JA, et al. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients. Ophthal Plast Reconstr Surg 2005 Sep; 21(5):337–344.
  • Savage MW, Sobel RK, Hoffman HT, Carter KD, Finkelstein MW, Shriver EM. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy. Ophthal Plast Reconstr Surg 2015 Jun; 31(3):e50–52.
  • Shepler TR, Sherman SI, Faustina M-M, Busaidy NL, Ahmadi MA, Esmaeli B. Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma. Ophthal Plast Reconstr Surg 2003 Nov; 19(6):479–481.
  • Groessl SA, Sires BS, Lemke BN. An anatomical basis for primary acquired nasolacrimal duct obstruction. Arch Ophthalmol 1997 Jan; 115(1):71–74.
  • McCormick A, Sloan B. The diameter of the nasolacrimal canal measured by computed tomography: gender and racial differences. Clin Experiment Ophthalmol 2009 May; 37(4):357–361.
  • Cetinkaya A, Kersten RC. Relationship between radioactive iodine therapy for thyroid carcinoma and nasolacrimal drainage system obstruction. Ophthal Plast Reconstr Surg 2007 Dec; 23(6):496.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.